Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan-Feb;12(1):6-9.
doi: 10.1016/j.jceh.2021.11.014. Epub 2021 Nov 29.

Liver Injury Following Tinospora Cordifolia Consumption: Drug-Induced AIH, or de novo AIH?

Einar S Björnsson  1   2 , Victor J Navarro  3 , Naga Chalasani  4
Affiliations
Editorial

Liver Injury Following Tinospora Cordifolia Consumption: Drug-Induced AIH, or de novo AIH?

Einar S Björnsson et al. J Clin Exp Hepatol. 2022 Jan-Feb.
No abstract available

Keywords: ANA, antinuclear antibody; DI-AIH, drug induced autoimmune hepatitis; DILI, drug-induced liver injury; HDS, herbal and dietary supplements; HPLC, high-performance liquid chromatography; PM, polygonum multiflorum; SMA, smooth muscle antibody; TC, T. cordifolia; TCM, traditional Chinese Medicine.

PubMed Disclaimer

References

    1. Andrade R.J., Lucena M.I., Fernández M.C., et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Spanish Group for the Study of Drug-Induced Liver Disease. Gastroenterology. 2005;129:512–521. - PubMed
    1. Björnsson E., Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42:481–489. - PubMed
    1. Björnsson E.S., Bergmann O.M., Björnsson H.K., et al. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144:1419–1425. - PubMed
    1. Chalasani N., Fontana R.J., Bonkovsky H.L., et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Drug Induced Liver Injury Network (DILIN) Gastroenterology. 2008;135:1924–1934. - PMC - PubMed
    1. Chalasani N., Bonkovsky H.L., Fontana R., et al. Features and outcomes of 899 patients with drug-induced liver injury. The DILIN prospective study Gastroenterology. 2015;48:1340–1352. - PMC - PubMed

Further reading

    1. Bjornsson Einar, Talwalkar Jay, Treeprasertsuk S., et al. Bjornsson E Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010;51:240–249. 14. - PubMed

Publication types